CompletedPhase 4ACTRN12612000491864

The Glucose Tolerance Test Study

The effect of glucose on acute changes in circulating IL-6 concentrations in overweight individuals.


Sponsor

Universtiy of otago

Enrollment

15 participants

Start Date

Aug 19, 2009

Study Type

Interventional

Conditions

Summary

Incretins are hormones that are produced in the intestine in response to food. The major increton is GLP-1 which directly stimulates the pancreas to produce insulin. The incretin effect is responsible for the greater insulin secretion seen after oral glucose intake compared to intravenous glucose. we postulate that after meal insulin changes are responsible for the reduction in circulating inflamatory marker IL-6 concentrations after an oral glucose tolerance test. If this is correct we believe that when the same amount of glucose is adminitered intravenously, due to a reduced insulin response, the after food decrease in IL-6 will be lessened.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 70 Yearss

Inclusion Criteria1

  • BMI > 27kg/m2 , have no ongoing health problems, not have diabetes, take no medication.

Exclusion Criteria1

  • Smoking, diabetes. Taking medications. BMI < 27kg/m2

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

After fasting overnight 16 Participants will be given 75g glucose to take orally, at a seperate visit they will be given 75g glucose intravenously. As a control these participants will be given water.

After fasting overnight 16 Participants will be given 75g glucose to take orally, at a seperate visit they will be given 75g glucose intravenously. As a control these participants will be given water. Following each 5 blood samples will be taken over a 2 hour period. There will be at least one week between each treatment.


Locations(1)

Otago, New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12612000491864